Medical optimization of lumbar fusion in the osteoporotic patient
Authors:
- 14 March 2018
- journal article
- review article
- Published by Springer Nature in Archives of Osteoporosis
- Vol. 13 (1) , 26
Abstract
In patients undergoing lumbar fusion, osteoporosis has been shown to lead to poorer outcomes and greater incidence of fusion-related complications. Given the undesirable effect of osteoporosis on lumbar fusion surgery, a number of medications have been proposed for use in the peri- and postoperative period to mitigate risks and enhance outcomes. The purpose of this review was to summarize and synthesize the current literature regarding medical management of osteoporosis in the context of lumbar fusion surgery.Keywords
This publication has 53 references indexed in Scilit:
- The US postmarketing surveillance study of adult osteosarcoma and teriparatide: Study design and findings from the first 7 yearsJournal of Bone and Mineral Research, 2012
- Effect of Dietary Calcium on Spinal Bone Fusion in an Ovariectomized Rat ModelJournal of Korean Neurosurgical Society, 2012
- The Influence of Alendronate on Spine Fusion in an Osteoporotic Animal ModelSpine, 2011
- Does alendronate disturb the healing process of posterior lumbar interbody fusion? A prospective randomized trialJournal of Neurosurgery: Spine, 2011
- Subsequent Vertebral Fractures Following Spinal Fusion Surgery for Degenerative Lumbar DiseaseSpine, 2010
- Fusion mass bone quality after uninstrumented spinal fusion in older patientsEuropean Spine Journal, 2010
- Effect of Teriparatide [rhPTH(1,34)] and Calcitonin on Intertransverse Process Fusion in a Rabbit ModelSpine, 2010
- The effect of anti-resorptive therapies on bone graft healing in an ovariectomized rat spinal arthrodesis modelBone, 2008
- Teriparatide or Alendronate in Glucocorticoid-Induced OsteoporosisNew England Journal of Medicine, 2007
- Progressive Junctional Kyphosis at the Caudal End of Lumbar Instrumented Fusion: Etiology, Predictors, and TreatmentSpine, 2006